IXICO plc (AIM:IXI)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 14.50
-1.00 (-6.45%)
Nov 5, 2026, 4:27 PM GMT
IXICO Market Cap
IXICO has a market cap or net worth of 31.75 million as of November 5, 2026. It is the 30,601st most valuable company in the world and the 680th biggest in the United Kingdom. Its market cap has increased by 204.56% in one year.
Market Cap
31.75M
Enterprise Value
30.64M
Revenue
7.28M
Global Rank
Country Rank
#680 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since October 15, 2013, IXICO's market cap has increased from 8.82M to 31.75M, an increase of 259.91%. That is a compound annual growth rate of 10.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 31.75M | 191.60% |
| Dec 31, 2025 | 10.89M | - |
| Dec 31, 2024 | 10.89M | 80.16% |
| Dec 29, 2023 | 6.04M | -50.98% |
| Dec 30, 2022 | 12.33M | -57.32% |
| Dec 31, 2021 | 28.89M | -40.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 4basebio | 77.69M |
| Faron Pharmaceuticals Oy | 62.99M |
| Ondine Biomedical | 52.19M |
| Poolbeg Pharma | 48.22M |
| Hemogenyx Pharmaceuticals | 43.52M |
| Arecor Therapeutics | 37.37M |
| Sareum Holdings | 25.36M |
| ImmuPharma | 22.01M |